NCT00249002View on ClinicalTrials.gov

Use of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients Undergoing Hemodialysis

PHASE2TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

November 1, 2005

Primary Completion Date

November 1, 2007

Study Completion Date

November 1, 2007

Conditions
Hemodialysis Graft Dysfunction
Interventions
DRUG

ABI-007

Trial Locations (4)

Unknown

Peoria

Shreveport

Rochester

Cincinnati

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY